August 20, 2022

MorphoSys AG (NASDAQ: MOR) is a name that has been making the rounds quite a bit, throughout social media chatter. The last 12 months have been tough on the German biopharmaceutical, seeing a fall of 63%. Weakening MOR Fundamentals One reason as to why the stock has been the talk of the town is due […]